foto
LATEST NEWS

OctoPlus enters into drug development and manufacturing contract with Ferring Pharmaceuticals A/S



WEBCAST HALF-YEAR RESULTS 2011

Click here to access the webcast of 29 July 2011



OCTOPLUS ANNUAL REPORT 2010
OCTO SHARE PRICE
HOME dashNL dash CONTACT
februari 4, 2012

 

PHARMACEUTICAL INNOVATORS

OctoPlus is a product-oriented drug delivery company focused on the development of improved pharmaceutical products with less side effects, increased patient compliance and better efficacy. Since our inception in 1995, we have established a successful track record and maintain partnerships with large and small biotech and pharma companies throughout the world.

Our business activities include formulation development services, drug delivery technologies and controlled release product development. Please use the menu to learn more about our activities.